Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

15-Year lipid profile effects on cardiovascular events adjusted for cardiovascular risk factors: a cohort study from Middle-East.

Sadeghi M, Golshahi J, Talaei M, Sheikhbahaei E, Ghodjani E, Mansouri M, Mansouri P, Sarrafzadegan N, Roohafza H.

Acta Cardiol. 2020 Feb 5:1-6. doi: 10.1080/00015385.2020.1717096. [Epub ahead of print]

PMID:
32019473
2.

High dietary acid load score is not associated with the risk of metabolic syndrome in Iranian adults.

Mohammadifard N, Karimi G, Khosravi A, Sarrafzadegan N, Jozan M, Zahed P, Haghighatdoost F.

Int J Vitam Nutr Res. 2020 Feb 5:1-12. doi: 10.1024/0300-9831/a000626. [Epub ahead of print]

PMID:
32019435
3.

Isfahan Twins Registry (ITR): An Invaluable Platform for Epidemiological and Epigenetic Studies: Design and Methodology of ITR.

Gharipour M, Haghjooy Javanmard S, Mansourian M, Sabri M, Khosravi E, Dianatkhah M, Sadeghian L, Jabarzare Z, Sarrafzadegan N.

Twin Res Hum Genet. 2020 Jan 20:1-4. doi: 10.1017/thg.2019.119. [Epub ahead of print]

PMID:
31955715
4.

Essential hypertension in children, a growing worldwide problem.

Sabri M, Gheissari A, Mansourian M, Mohammadifard N, Sarrafzadegan N.

J Res Med Sci. 2019 Dec 23;24:109. doi: 10.4103/jrms.JRMS_641_19. eCollection 2019. Review.

5.

Development and evaluation of the psychometric properties of a hypertension self-care questionnaire.

Eghbali-Babadi M, Feizi A, Khosravi A, Nouri F, Taheri M, Sarrafzadegan N.

ARYA Atheroscler. 2019 Sep;15(5):241-249. doi: 10.22122/arya.v15i5.1835.

6.

Design and methodology of heart failure registry: Results of the Persian registry of cardiovascular disease.

Givi M, Heshmat-Ghahdarijani K, Garakyaraghi M, Yadegarfar G, Vakhshoori M, Heidarpour M, Shafie D, Sarrafzadegan N.

ARYA Atheroscler. 2019 Sep;15(5):228-232. doi: 10.22122/arya.v15i5.1950.

7.

The interplay of endothelial dysfunction, cardiovascular disease, and cancer: What we should know beyond inflammation and oxidative stress.

Masoudkabir F, Sarrafzadegan N.

Eur J Prev Cardiol. 2019 Dec 18:2047487319895415. doi: 10.1177/2047487319895415. [Epub ahead of print] No abstract available.

PMID:
31852299
8.

Correlation between air pollution and hospitalization due to myocardial infarction.

Davoodabadi Z, Soleimani A, Pourmoghaddas A, Hosseini SM, Jafari-Koshki T, Rahimi M, Shishehforoush M, Lahijanzadeh A, Sadeghian B, Moazam E, Mohebi MB, Ezatian V, Rabiei K, Sarrafzadegan N.

ARYA Atheroscler. 2019 Jul;15(4):161-167. doi: 10.22122/arya.v15i4.1834.

9.

Factors Associated With Low-Density Lipoprotein Cholesterol Reduction in Patients With Familial Hypercholesterolemia: Results From Isfahan Familial Hypercholesterolemia Registry.

Vaseghi G, Jamalin M, Arabi S, Kheiri S, Hajian S, Sarrafzadegan N.

Am J Ther. 2019 Dec 6. doi: 10.1097/MJT.0000000000001087. [Epub ahead of print] No abstract available.

PMID:
31815752
10.

Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: Baseline data from DieTBra trial.

Santos ASAC, Rodrigues APS, Rosa LPS, Sarrafzadegan N, Silveira EA.

Nutr Metab Cardiovasc Dis. 2019 Nov 5. pii: S0939-4753(19)30409-0. doi: 10.1016/j.numecd.2019.10.010. [Epub ahead of print]

PMID:
31791637
11.

Promoting Patient Utilization of Outpatient Cardiac Rehabilitation: A JOINT INTERNATIONAL COUNCIL AND CANADIAN ASSOCIATION OF CARDIOVASCULAR PREVENTION AND REHABILITATION POSITION STATEMENT.

Santiago de Araújo Pio C, Beckie TM, Varnfield M, Sarrafzadegan N, Babu AS, Baidya S, Buckley J, Chen SY, Gagliardi A, Heine M, Khiong JS, Mola A, Radi B, Supervia M, Trani MR, Abreu A, Sawdon JA, Moffatt PD, Grace SL.

J Cardiopulm Rehabil Prev. 2019 Nov 22. doi: 10.1097/HCR.0000000000000474. [Epub ahead of print]

PMID:
31764535
12.

Trend of salt intake measured by 24-hour urine collection samples among Iranian adults population between 1998 and 2013: The Isfahan salt study.

Mohammadifard N, Khosravi A, Salas-Salvadó J, Becerra-Tomás N, Nouri F, Abdollahi Z, Jozan M, Bahonar A, Sarrafzadegan N.

Nutr Metab Cardiovasc Dis. 2019 Dec;29(12):1323-1329. doi: 10.1016/j.numecd.2019.07.019. Epub 2019 Jul 27.

PMID:
31672449
13.

A database for using machine learning and data mining techniques for coronary artery disease diagnosis.

Alizadehsani R, Roshanzamir M, Abdar M, Beykikhoshk A, Khosravi A, Panahiazar M, Koohestani A, Khozeimeh F, Nahavandi S, Sarrafzadegan N.

Sci Data. 2019 Oct 23;6(1):227. doi: 10.1038/s41597-019-0206-3.

14.

Can methods based on spot urine samples be used to estimate average population 24 h sodium excretion? Results from the Isfahan Salt Study.

Mohammadifard N, Marateb H, Mansourian M, Khosravi A, Abdollahi Z, Campbell NR, Webster J, Petersen K, Sarrafzadegan N.

Public Health Nutr. 2020 Feb;23(2):202-213. doi: 10.1017/S136898001900257X. Epub 2019 Sep 24.

PMID:
31547894
15.

Nature of Cardiac Rehabilitation Around the Globe.

Supervia M, Turk-Adawi K, Lopez-Jimenez F, Pesah E, Ding R, Britto RR, Bjarnason-Wehrens B, Derman W, Abreu A, Babu AS, Santos CA, Jong SK, Cuenza L, Yeo TJ, Scantlebury D, Andersen K, Gonzalez G, Giga V, Vulic D, Vataman E, Cliff J, Kouidi E, Yagci I, Kim C, Benaim B, Estany ER, Fernandez R, Radi B, Gaita D, Simon A, Chen SY, Roxburgh B, Martin JC, Maskhulia L, Burdiat G, Salmon R, Lomelí H, Sadeghi M, Sovova E, Hautala A, Tamuleviciute-Prasciene E, Ambrosetti M, Neubeck L, Asher E, Kemps H, Eysymontt Z, Farsky S, Hayward J, Prescott E, Dawkes S, Santibanez C, Zeballos C, Pavy B, Kiessling A, Sarrafzadegan N, Baer C, Thomas R, Hu D, Grace SL.

EClinicalMedicine. 2019 Jul 4;13:46-56. doi: 10.1016/j.eclinm.2019.06.006. eCollection 2019 Aug.

16.

Cardiac Rehabilitation Availability and Density around the Globe.

Turk-Adawi K, Supervia M, Lopez-Jimenez F, Pesah E, Ding R, Britto RR, Bjarnason-Wehrens B, Derman W, Abreu A, Babu AS, Santos CA, Jong SK, Cuenza L, Yeo TJ, Scantlebury D, Andersen K, Gonzalez G, Giga V, Vulic D, Vataman E, Cliff J, Kouidi E, Yagci I, Kim C, Benaim B, Estany ER, Fernandez R, Radi B, Gaita D, Simon A, Chen SY, Roxburgh B, Martin JC, Maskhulia L, Burdiat G, Salmon R, Lomelí H, Sadeghi M, Sovova E, Hautala A, Tamuleviciute-Prasciene E, Ambrosetti M, Neubeck L, Asher E, Kemps H, Eysymontt Z, Farsky S, Hayward J, Prescott E, Dawkes S, Santibanez C, Zeballos C, Pavy B, Kiessling A, Sarrafzadegan N, Baer C, Thomas R, Hu D, Grace SL.

EClinicalMedicine. 2019 Jul 3;13:31-45. doi: 10.1016/j.eclinm.2019.06.007. eCollection 2019 Aug.

17.

Temporal trend analysis of stroke and salt intake: a 15-year population-based study.

Arsang-Jang S, Mansourian M, Mohammadifard N, Khosravi A, Oveis-Gharan S, Nouri F, Sarrafzadegan N.

Nutr Neurosci. 2019 Sep 13:1-11. doi: 10.1080/1028415X.2019.1638665. [Epub ahead of print]

PMID:
31514683
18.

The effect of educational and encouragement interventions on anthropometric characteristics, obestatin and adiponectin levels.

Sajjadi F, Mohammadifard N, Maghroun M, Shirani F, Karimi S, Taheri M, Sarrafzadegan N.

ARYA Atheroscler. 2019 May;15(3):123-129. doi: 10.22122/arya.v15i3.1588.

19.

Association between ambient air pollution and hospitalization caused by atrial fibrillation.

Saifipour A, Azhari A, Pourmoghaddas A, Hosseini SM, Jafari-Koshki T, Rahimi M, Nasri A, Shishehforoush M, Lahijanzadeh A, Sadeghian B, Moazam E, Mohebi MB, Ezatian V, Rabiei K, Sarrafzadegan N.

ARYA Atheroscler. 2019 May;15(3):106-112. doi: 10.22122/arya.v15i3.1843.

20.

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.

Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, Ostovaneh MR, Nateghi A, Majed M, Navabakhsh B, Merat S, Pourshams A, Nalini M, Malekzadeh F, Sadeghi M, Mohammadifard N, Sarrafzadegan N, Naemi-Tabiei M, Fazel A, Brennan P, Etemadi A, Boffetta P, Thomas N, Marshall T, Cheng KK, Malekzadeh R.

Lancet. 2019 Aug 24;394(10199):672-683. doi: 10.1016/S0140-6736(19)31791-X.

PMID:
31448738
21.

CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design.

Vaseghi G, Arabi S, Haghjooy-Javanmard S, Sabri M, Sadeghi M, Khosravi A, Zarfeshani S, Sarrafzadegan N.

ARYA Atheroscler. 2019 Mar;15(2):53-58. doi: 10.22122/arya.v15i2.1899.

22.

Promoting patient utilization of outpatient cardiac rehabilitation: A joint International Council and Canadian Association of Cardiovascular Prevention and Rehabilitation position statement.

Santiago de Araújo Pio C, Beckie TM, Varnfield M, Sarrafzadegan N, Babu AS, Baidya S, Buckley J, Chen SY, Gagliardi A, Heine M, Khiong JS, Mola A, Radi B, Supervia M, Trani MR, Abreu A, Sawdon JA, Moffatt PD, Grace SL.

Int J Cardiol. 2020 Jan 1;298:1-7. doi: 10.1016/j.ijcard.2019.06.064. Epub 2019 Jul 4.

PMID:
31405584
23.

Machine learning-based coronary artery disease diagnosis: A comprehensive review.

Alizadehsani R, Abdar M, Roshanzamir M, Khosravi A, Kebria PM, Khozeimeh F, Nahavandi S, Sarrafzadegan N, Acharya UR.

Comput Biol Med. 2019 Aug;111:103346. doi: 10.1016/j.compbiomed.2019.103346. Epub 2019 Jul 4. Review.

PMID:
31288140
24.

Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria.

Gharipour M, Sadeghi M, Nezafati P, Dianatkhah M, Sarrafzadegan N.

J Res Health Sci. 2019 May 13;19(2):e00442.

PMID:
31278212
25.

Anthropometric indices predicting incident hypertension in an Iranian population: The Isfahan cohort study.

Sadeghi M, Talaei M, Gharipour M, Oveisgharan S, Nezafati P, Dianatkhah M, Sarrafzadegan N.

Anatol J Cardiol. 2019 Jun;22(1):33-43. doi: 10.14744/AnatolJCardiol.2019.10594.

26.

Cardiac rehabilitation delivery in low/middle-income countries.

Pesah E, Turk-Adawi K, Supervia M, Lopez-Jimenez F, Britto R, Ding R, Babu A, Sadeghi M, Sarrafzadegan N, Cuenza L, Anchique Santos C, Heine M, Derman W, Oh P, Grace SL.

Heart. 2019 Dec;105(23):1806-1812. doi: 10.1136/heartjnl-2018-314486. Epub 2019 Jun 28.

PMID:
31253695
27.

Long-term association of nut consumption and cardiometabolic risk factors.

Mohammadifard N, Haghighatdoost F, Mansourian M, Hassannejhad R, Sadeghi M, Roohafza H, Sajjadi F, Maghroun M, Alikhasi H, Sarrafzadegan N.

Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):972-982. doi: 10.1016/j.numecd.2019.04.014. Epub 2019 May 8.

PMID:
31248717
28.

Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.

Mazloumi E, Poorolajal J, Sarrafzadegan N, Roohafza HR, Faradmal J, Karami M.

High Blood Press Cardiovasc Prev. 2019 Jun;26(3):227-237. doi: 10.1007/s40292-019-00319-3. Epub 2019 Jun 21.

PMID:
31228169
29.

Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.

Mansourian M, Babahajiani M, Jafari-Koshki T, Roohafza H, Sadeghi M, Sarrafzadegan N.

Metab Syndr Relat Disord. 2019 Sep;17(7):362-366. doi: 10.1089/met.2018.0136. Epub 2019 Jun 12.

PMID:
31188051
30.

Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review.

Heidarpour M, Shafie D, Aminorroaya A, Sarrafzadegan N, Farajzadegan Z, Nouri R, Najimi A, Dimopolou C, Stalla G.

J Res Med Sci. 2019 Apr 26;24:29. doi: 10.4103/jrms.JRMS_955_18. eCollection 2019. Review.

31.

The association between the serum 25-hydroxyvitamin D level and cardiovascular events in individuals with and without metabolic syndrome.

Kiani K, Roohafza H, Gharipour M, Dianatkhah M, Talaei M, Oveisgharan S, Sarrafzadegan N, Sadeghi M.

ARYA Atheroscler. 2018 Nov;14(6):254-259. doi: 10.22122/arya.v14i6.1703.

33.

Dietary patterns in relation to lipid profiles among Iranian adults.

Zaribaf F, Mohammadifard N, Sarrafzadegan N, Karimi G, Gholampour A, Azadbakht L.

J Cardiovasc Thorac Res. 2019;11(1):19-27. doi: 10.15171/jcvtr.2019.04. Epub 2019 Mar 13.

34.

Availability and delivery of cardiac rehabilitation in the Eastern Mediterranean Region: How does it compare globally?

Turk-Adawi K, Supervia M, Pesah E, Lopez-Jimenez F, Afaneh J, El-Heneidy A, Sadeghi M, Sarrafzadegan N, Alhashemi M, Papasavvas T, Grace SL.

Int J Cardiol. 2019 Jun 15;285:147-153. doi: 10.1016/j.ijcard.2019.02.065. Epub 2019 Mar 14.

PMID:
30904282
35.

Proposal of a study protocol of a preliminary double-blind randomized controlled trial. Verifying effects of selenium supplementation on selenoprotein p and s genes expression in protein and mRNA levels in subjects with coronary artery disease: selenegene.

Gharipour M, Sadeghi M, Behmanesh M, Salehi M, Roohafza H, Nezafati P, Khosravi E, Hosseini M, Keshvari M, Rouhi-Bourojeni H, Sarrafzadegan N.

Acta Biomed. 2019 Jan 22;90(1):44-50. doi: 10.23750/abm.v90i1.6167.

36.

Low correlation between morning spot and 24-hour urine samples for estimating sodium intake in an Iranian population: Isfahan Salt Study.

Khosravi A, Mohammadifard N, Gharipour M, Abdollahi Z, Nouri F, Feizi A, Jozan M, Sarrafzadegan N.

Int J Vitam Nutr Res. 2019 Sep;89(3-4):185-191. doi: 10.1024/0300-9831/a000558. Epub 2019 Mar 19.

PMID:
30887904
37.

Decreased Na+/K+-ATPase Activity and Altered Susceptibility to Peroxidation and Lipid Composition in the Erythrocytes of Metabolic Syndrome Patients with Coronary Artery Disease.

Namazi G, Asa P, Sarrafzadegan N, Pourfarzam M.

Ann Nutr Metab. 2019;74(2):140-148. doi: 10.1159/000497065. Epub 2019 Feb 7. Erratum in: Ann Nutr Metab. 2019;74(3):264.

PMID:
30731468
38.

The Effect of Parental Medical History on the Prevalence of Cerebrovascular Diseases in Their Children in an Iranian Population.

Khosravi A, Behjati M, Dianatkhah M, Noori F, Sarrafzadegan N, Nejati M.

Basic Clin Neurosci. 2018 Sep-Oct;9(5):367-372. doi: 10.32598/bcn.9.5.367. Epub 2018 Sep 1.

39.
40.

Determinants of Changes in Metabolic Syndrome Components in a 12-Year Cohort of Iranian Adults.

Khosravi-Boroujeni H, Sarrafzadegan N, Sadeghi M, Roohafza H, Ng SK, Ahmed F.

Metab Syndr Relat Disord. 2019 Mar;17(2):120-127. doi: 10.1089/met.2018.0026. Epub 2019 Jan 8.

PMID:
30620241
41.

Are dietary patterns differently associated with differentiated levels of mental health problems? Results from a large cross-sectional study among Iranian manufacturing employees.

Heidari Z, Feizi A, Roohafza H, Rabiei K, Sarrafzadegan N.

BMJ Open. 2019 Jan 7;9(1):e020083. doi: 10.1136/bmjopen-2017-020083.

42.

A 10-year Isfahan cohort on cardiovascular disease as a master plan for a multi-generation non-communicable disease longitudinal study: methodology and challenges.

Sarrafzadegan N, Hassannejad R, Roohafza H, Sadeghi M, Talaei M, Oveisgharan S, Mansourian M.

J Hum Hypertens. 2019 Nov;33(11):807-816. doi: 10.1038/s41371-018-0126-2. Epub 2018 Nov 1.

PMID:
30385824
43.

World No Tobacco Day 2018: towards a sustainable campaign involving the cardiovascular community (Editorial).

El-Awa F, Sarrafzadegan N, Slama S, Hammerich A.

East Mediterr Health J. 2018 Jul 17;24(5):409-410. doi: 10.26719/2018.24.5.409.

44.

Methods of sampling and sample size determination of a comprehensive integrated community-based interventional trial: Isfahan Healthy Heart Program.

Nouri F, Feizi A, Mohammadifard N, Sarrafzadegan N.

ARYA Atheroscler. 2018 Mar;14(2):58-70. doi: 10.22122/arya.v14i2.1488.

45.

The relationship between serum vitamin D levels and ankle-brachial index in patients with metabolic syndrome.

Kazemisaleh D, Kiani K, Sadeghi M, Roohafza H, Dianatkhah M, Sarrafzadegan N.

ARYA Atheroscler. 2018 Jan;14(1):11-16. doi: 10.22122/arya.v14i1.1664.

46.

Effects of selenium supplementation on expression of SEPP1 in mRNA and protein levels in subjects with and without metabolic syndrome suffering from coronary artery disease: Selenegene study a double-blind randomized controlled trial.

Gharipour M, Ouguerram K, Nazih EH, Salehi M, Behmanesh M, Roohafza H, Hosseini SM, Nezafati P, Dianatkhah M, Gharipour A, Haghjoo S, Sarrafzadegan N, Sadeghi M.

J Cell Biochem. 2018 Nov;119(10):8282-8289. doi: 10.1002/jcb.26844. Epub 2018 Jun 22.

PMID:
29932230
47.

Non-invasive detection of coronary artery disease in high-risk patients based on the stenosis prediction of separate coronary arteries.

Alizadehsani R, Hosseini MJ, Khosravi A, Khozeimeh F, Roshanzamir M, Sarrafzadegan N, Nahavandi S.

Comput Methods Programs Biomed. 2018 Aug;162:119-127. doi: 10.1016/j.cmpb.2018.05.009. Epub 2018 May 10.

PMID:
29903478
48.

Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran.

Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N.

Epidemiol Health. 2018 May 18;40:e2018020. doi: 10.4178/epih.e2018020. eCollection 2018.

49.

Long-term nuts intake and metabolic syndrome: A 13-year longitudinal population-based study.

Hassannejad R, Mohammadifard N, Kazemi I, Mansourian M, Sadeghi M, Roohafza H, Sarrafzadegan N.

Clin Nutr. 2019 Jun;38(3):1246-1252. doi: 10.1016/j.clnu.2018.05.006. Epub 2018 May 14.

PMID:
29801674
50.

Usual energy and macronutrient intakes in a large sample of Iranian middle-aged and elderly populations.

Heidari Z, Feizi A, Azadbakht L, Mohammadifard N, Maghroun M, Sarrafzadegan N.

Nutr Diet. 2019 Apr;76(2):174-183. doi: 10.1111/1747-0080.12431. Epub 2018 May 10.

PMID:
29749015

Supplemental Content

Loading ...
Support Center